artesunic acid has been researched along with Adverse Drug Event in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Baiden, R; Binka, F; Compaore, A; Diande, NA; Hien, FS; Rouamba, T; Sondo, P; Tahita, MC; Tinto, H; Traore-Coulibaly, M; Valea, I; Yerbanga, IW | 1 |
| Akakpo, S; Ampadu, HH; Asante, KP; Bosomprah, S; Dodoo, ANO; Gardarsdottir, H; Hugo, P; Kajungu, D; Leufkens, HGM | 1 |
| Arbe-Barnes, S; Borghini-Fuhrer, I; Craft, CJ; Duparc, S; Fleckenstein, L; Miller, RM; Shin, CS | 1 |
| Burchard, GD; Cramer, JP; Kluge, S; Rolling, T; Schmiedel, S; Wichmann, D | 1 |
| Berens-Riha, N; Bountogo, M; Bousema, T; Breitkreutz, J; Coulibaly, B; Drakeley, C; Kieser, M; Klose, C; Meissner, PE; Mockenhaupt, FP; Müller, O; Nebié, E; Pritsch, M; Schirmer, RH; Sié, A; Sirima, SB; Wieser, A | 1 |
| Carn, G; Jullien, V; Juma, E; Kiechel, JR; Obonyo, C; Ogutu, B; Taylor, WR; Vaillant, M | 1 |
| Gan, SH; Yusof, W | 1 |
| Efferth, T; Kaina, B | 1 |
| Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Poravuth, Y; Purnama, A; Pyae Phyo, A; Rao, BH; Rueangweerayut, R; Shin, CS; Socheat, D; Tjitra, E; Uthaisin, C; Valecha, N | 1 |
| Balbiano, R; Calleri, G; Caramello, P; Chiriotto, M; De Blasi, T; Deagostini, M | 1 |
| Bacchieri, A; Bhattacharyya, PC; Corsi, M; Dev, V; Dubashi, N; Gargano, N; Ghosh, SK; Kumar, A; Rao, BH; Srivastava, B; Tommasini, S; Ubben, D; Valecha, N | 1 |
| Abbara, A; Cargill, T; Davidson, RN; Eder, M; Farne, H | 1 |
| Coulibaly, B; Klose, C; Kouyaté, B; Mansmann, U; Meissner, P; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I; Zoungrana, A | 1 |
1 review(s) available for artesunic acid and Adverse Drug Event
| Article | Year |
|---|---|
Toxicity of the antimalarial artemisinin and its dervatives.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Developing Countries; Dogs; Drug Administration Routes; Drug-Related Side Effects and Adverse Reactions; Humans; Malaria; Rabbits; Rats; Sesquiterpenes | 2010 |
6 trial(s) available for artesunic acid and Adverse Drug Event
| Article | Year |
|---|---|
Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA).
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Diarrhea; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Follow-Up Studies; Ghana; Humans; Injections; Longitudinal Studies; Male; Prospective Studies; Uganda; Young Adult | 2018 |
Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Microscopy; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2015 |
Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Treatment Outcome; Young Adult | 2014 |
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Time Factors; Treatment Outcome; Young Adult | 2011 |
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2012 |
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
Topics: Amodiaquine; Artemisinins; Artesunate; Burkina Faso; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Dysuria; Humans; Malaria, Falciparum; Methylene Blue; Sesquiterpenes; Treatment Outcome; Vomiting | 2008 |
6 other study(ies) available for artesunic acid and Adverse Drug Event
| Article | Year |
|---|---|
Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine-artesunate in a rural health district in Burkina Faso.
Topics: Antimalarials; Artemisinins; Artesunate; Burkina Faso; Chemical and Drug Induced Liver Injury; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Malaria; Naphthyridines; Rural Health | 2022 |
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2013 |
Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis.
Topics: Adult; Anemia, Hemolytic; Antimalarials; Artemisinins; Artesunate; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Human Migration; Humans; Malaria; Male; Middle Aged; Quinine; Retrospective Studies | 2013 |
High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population.
Topics: Alleles; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2A6; Drug-Related Side Effects and Adverse Reactions; Gene Frequency; Genotype; Humans; Malaysia; Polymerase Chain Reaction; Randomized Controlled Trials as Topic | 2009 |
Severe malaria, artesunate and haemolysis.
Topics: Antimalarials; Artemisinins; Artesunate; Drug-Related Side Effects and Adverse Reactions; Female; Hemolysis; Humans; Malaria, Falciparum; Young Adult | 2012 |
Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Artemisinins; Artesunate; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Length of Stay; Malaria, Falciparum; Male; Middle Aged; Quinine; Retrospective Studies; Survival Analysis; Travel; Treatment Outcome; United Kingdom; Young Adult | 2012 |